Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising:
(a) a prostaglandin vasodilator;
(b) 15-hydroxyprostaglandindehydrogenase inhibitor: and
(c) a base material that is solid at room temperature and releases components (a) and (b) when inserted in the urethra,
is effective for the treatment of male erectile dysfunction.
Abstract: Administration of a pharmaceutical composition in the form of a suppository comprising:
(a) a prostaglandin vasodilator;
(b) 15-hydroxyprostaglandindehydrogenase inhibitor; and
(c) a base material that is solid at room temperature and releases components (a) and (b) when inserted in the urethra,
is effective for the treatment of male erectile dysfunction.
Abstract: Administration of a pharmaceutical composition comprising:
(a) a vasodilator; and
(b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.
Abstract: Administration of a pharmaceutical composition comprising:(a) a vasodilator; and(b) a 15-hydroxyprostaglandindehydrogenase inhibitor is effective for the treatment of male erectile dysfunction.